Clinical Trials Logo

Filter by:
NCT ID: NCT06412198 Not yet recruiting - Clinical trials for Metastatic Colorectal Cancer

A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations

Start date: November 30, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

To learn if the drug combination of adagrasib, cetuximab, and cemiplimab can help to control metastatic CRC with KRAS G12C mutations.

NCT ID: NCT06412120 Not yet recruiting - Ovarian Cancer Clinical Trials

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

Start date: September 1, 2024
Phase: Phase 4
Study type: Interventional

The purpose of this study is to identify the genetic characteristic(s), specifically degree of African ancestry, and environmental characteristic(s) that appear to be related to the effects, both good and bad, that the maintenance treatment has women with ovarian cancer. In this study, an investigational medication called niraparib is being tested for the treatment of ovarian cancer. Niraparib works by blocking the ability of cancer cells to fix their genes. Cancer cells with damaged genes have a harder time growing and spreading in the body and can even die.

NCT ID: NCT06411756 Not yet recruiting - Clinical trials for Colorectal Neoplasms

Physical Activity Centers Empowerment

PACE
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This research study tests the feasibility of the Physical Activity Centers Empowerment (PACE) physical activity intervention for African American individuals diagnosed with colorectal cancer. Feasibility will be measured as intervention reach, effectiveness, adoption, implementation, and maintenance. Seventy-two subjects will be recruited to conduct a pilot two-group, randomized repeated measures study.

NCT ID: NCT06411691 Not yet recruiting - Colorectal Cancer Clinical Trials

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

Start date: August 2024
Phase: Phase 2
Study type: Interventional

Phase 2 study evaluating the efficacy and immune response to a synthetic long peptide mutant KRAS vaccine (SPL mKRASvax) combined with Balstilimab and Botensilimab for unresectable or metastatic mismatch repair-proficient (MMR-p) colorectal cancer (mCRC) or unresectable or metastatic MMR-p pancreatic ductal adenocarcinoma (PDAC) patients with measurable disease following first-line FOLFIRINOX/FOLFOXIRI (FFX).

NCT ID: NCT06411548 Not yet recruiting - Clinical trials for Type 1 Diabetes Mellitus

Insulearn Feasibility With MDI

InsuLearn
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This is a 24-hour, randomized, crossover, single-center trial where participants are randomized to either start with the InsuLearn intervention or the usual care (UC) intervention. In the InsuLearn intervention, insulin doses are optimized using data collected in a 4-weeks at home data collection period.

NCT ID: NCT06411223 Not yet recruiting - Hiv Clinical Trials

Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs

Start date: June 1, 2024
Phase: Phase 2
Study type: Interventional

This study addresses real-world use of long-acting injectable cabotegravir/rilpivirine (CAB/RPV LA) by evaluating implementation and clinical outcomes of a pharmacist-led collaborative drug therapy management model (CDTM+) that will be expanded for telehealth outreach to women with health-related social needs (HRSN).

NCT ID: NCT06411210 Not yet recruiting - Obesity Clinical Trials

Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment

Start date: June 17, 2024
Phase: Phase 2
Study type: Interventional

More than 40% of young adults with type 1 diabetes (T1D) also have overweight or obesity. Each of these diagnoses increase the risk of adverse cardiovascular events. GLP-1 analogues are anti-obesity medications that are cardioprotective in adults with type 2 diabetes, however evaluation of these agents in people with T1D has been limited to glycemic outcomes. Investigators aim to study the impact of GLP-1 analogue obesity treatment on markers of cardiometabolic risk in young adults with T1D and obesity.

NCT ID: NCT06411158 Not yet recruiting - Clinical trials for Urinary Incontinence

Training for Urinary Leakage Improvement After Pregnancy

TULIP
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This is a multi-center, randomized single-blind nonsurgical trial conducted in approximately 216 primiparous postpartum women at high risk for prolonged/sustained pelvic floor disorders with symptomatic, bothersome urinary incontinence (UI) amenable to nonsurgical treatment. TULIP is a 3-Arm trial with two active interventions (Arms 1 and 2) and a Patient Education control arm (Arm 3). Arm 1 consists of pelvic floor muscle training (PFMT). Arm 2 uses a home biofeedback device (leva®). The primary outcome will be assessed at 6 months postpartum by blinded outcomes assessors, and follow-up will continue until 12 months postpartum.

NCT ID: NCT06410989 Not yet recruiting - Stroke Clinical Trials

Evaluation of Sensorimotor Ankle Impairments in Chronic Stroke

Start date: May 20, 2024
Phase:
Study type: Observational

The purpose of this study is to capture sensorimotor ankle function in a chronic stroke population through validation of novel, experimental metrics and their comparison with established, clinical measures of function. For this purpose, the researchers will evaluate various single-joint, impairment-level measures such as visuomotor tracking performance and proprioception as well as functional-level measures including spatiotemporal gait (e.g., gait speed and stride length/time) and standardized clinical scales. This study will be carried out in chronic stroke patients as well as age-matched healthy controls. Results will help the researchers identify more quantitative metrics that can be used to monitor and rehabilitate sensorimotor function following stroke.

NCT ID: NCT06410807 Not yet recruiting - Aging Clinical Trials

Development of Web-Based Mind-Body Trainings for Adults With Subjective Concerns

iMBT
Start date: August 2024
Phase:
Study type: Observational

The goal of this observational study is to develop online, self-paced mindfulness (iMBSR) and lifestyle education (iLifeEd) programs for adults with cognitive concerns. Participants will engage in focus groups to discuss healthy living, web-based behavioral interventions, intervention content/format and ideal outcomes after engaging in behavioral interventions that promote healthy living. Additionally, participants will provide feedback on the protocol and online platform for either iMBSR or iLifeEd. This feedback will be used to refine the iMBSR and iLifeEd protocols for future use in the randomized controlled trial portion of the parent project.